Literature DB >> 18485364

Structural studies on the co-chaperone Hop and its complexes with Hsp90.

S C Onuoha1, E T Coulstock, J G Grossmann, S E Jackson.   

Abstract

The tetratricopeptide repeat domain (TPR)-containing co-chaperone Hsp-organising protein (Hop) plays a critical role in mediating interactions between Heat Shock Protein (Hsp)70 and Hsp90 as part of the cellular assembly machine. It also modulates the ATPase activity of both Hsp70 and Hsp90, thus facilitating client protein transfer between the two. Despite structural work on the individual domains of Hop, no structure for the full-length protein exists, nor is it clear exactly how Hop interacts with Hsp90, although it is known that its primary binding site is the C-terminal MEEVD motif. Here, we have undertaken a biophysical analysis of the structure and binding of Hop to Hsp90 using a variety of truncation mutants of both Hop and Hsp90, in addition to mutants of Hsp90 that are thought to modulate the conformation, in particular the N-terminal dimerisation of the chaperone. The results establish that whilst the primary binding site of Hop is the C-terminal MEEVD peptide of Hsp90, binding also occurs at additional sites in the C-terminal and middle domain. In contrast, we show that another TPR-containing co-chaperone, CyP40, binds solely to the C-terminus of Hsp90. Truncation mutants of Hop were generated and used to investigate the dimerisation interface of the protein. In good agreement with recently published data, we find that the TPR2a domain that contains the Hsp90-binding site is also the primary site for dimerisation. However, our results suggest that residues within the TPR2b may play a role. Together, these data along with shape reconstruction analysis from small-angle X-ray scattering measurements are used to generate a solution structure for full-length Hop, which we show has an overall butterfly-like quaternary structure. Studies on the nucleotide dependence of Hop binding to Hsp90 establish that Hop binds to the nucleotide-free, 'open' state of Hsp90. However, the Hsp90-Hop complex is weakened by the conformational changes that occur in Hsp90 upon ATP binding. Together, the data are used to propose a detailed model of how Hop may help present the client protein to Hsp90 by aligning the bound client on Hsp70 with the middle domain of Hsp90. It is likely that Hop binds to both monomers of Hsp90 in the form of a clamp, interacting with residues in the middle domain of Hsp90, thus preventing ATP hydrolysis, possibly by the prevention of association of N-terminal and middle domains in individual Hsp90 monomers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18485364     DOI: 10.1016/j.jmb.2008.02.013

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  50 in total

1.  Hsp 70/Hsp 90 organizing protein as a nitrosylation target in cystic fibrosis therapy.

Authors:  Nadzeya V Marozkina; Sean Yemen; Molly Borowitz; Lei Liu; Melissa Plapp; Fei Sun; Rafique Islam; Petra Erdmann-Gilmore; R Reid Townsend; Cheryl F Lichti; Sneha Mantri; Phillip W Clapp; Scott H Randell; Benjamin Gaston; Khalequz Zaman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-08       Impact factor: 11.205

2.  Advances in the discovery and development of heat-shock protein 90 inhibitors for cancer treatment.

Authors:  Hardik J Patel; Shanu Modi; Gabriela Chiosis; Tony Taldone
Journal:  Expert Opin Drug Discov       Date:  2011-05       Impact factor: 6.098

3.  The architecture of functional modules in the Hsp90 co-chaperone Sti1/Hop.

Authors:  Andreas B Schmid; Stephan Lagleder; Melissa Ann Gräwert; Alina Röhl; Franz Hagn; Sebastian K Wandinger; Marc B Cox; Oliver Demmer; Klaus Richter; Michael Groll; Horst Kessler; Johannes Buchner
Journal:  EMBO J       Date:  2012-01-06       Impact factor: 11.598

Review 4.  Versatile TPR domains accommodate different modes of target protein recognition and function.

Authors:  Rudi Kenneth Allan; Thomas Ratajczak
Journal:  Cell Stress Chaperones       Date:  2010-12-09       Impact factor: 3.667

Review 5.  Heat shock protein 70 (hsp70) as an emerging drug target.

Authors:  Christopher G Evans; Lyra Chang; Jason E Gestwicki
Journal:  J Med Chem       Date:  2010-06-24       Impact factor: 7.446

6.  A proteomic investigation of ligand-dependent HSP90 complexes reveals CHORDC1 as a novel ADP-dependent HSP90-interacting protein.

Authors:  Jacob J Gano; Julian A Simon
Journal:  Mol Cell Proteomics       Date:  2009-10-28       Impact factor: 5.911

7.  HOP is a monomer: investigation of the oligomeric state of the co-chaperone HOP.

Authors:  Fang Yi; Ivo Doudevski; Lynne Regan
Journal:  Protein Sci       Date:  2010-01       Impact factor: 6.725

Review 8.  New developments in Hsp90 inhibitors as anti-cancer therapeutics: mechanisms, clinical perspective and more potential.

Authors:  Yanyan Li; Tao Zhang; Steven J Schwartz; Duxin Sun
Journal:  Drug Resist Updat       Date:  2009 Feb-Apr       Impact factor: 18.500

Review 9.  Novobiocin and additional inhibitors of the Hsp90 C-terminal nucleotide-binding pocket.

Authors:  Alison Donnelly; Brian S J Blagg
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

10.  Modeling signal propagation mechanisms and ligand-based conformational dynamics of the Hsp90 molecular chaperone full-length dimer.

Authors:  Giulia Morra; Gennady Verkhivker; Giorgio Colombo
Journal:  PLoS Comput Biol       Date:  2009-03-20       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.